The report released yesterday that found the US investment in the Human Genome Project and later genomics funding has generated $965 billion in economic impact stirred up some skeptical pushback from critics, according to Nature's Meredith Wadman.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Moving Money Around

The Slight Difference

Use in Court

In a Name

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.